Nicole J. Ullrich, M.D., Ph.D.
Affiliations: | Neurology | Harvard Medical School, Boston, MA, United States |
Area:
Neuro-oncologyGoogle:
"Nicole Ullrich"Mean distance: 15.51 (cluster 11) | S | N | B | C | P |
Cross-listing:
Parents
Sign in to add mentor| Scott L. Pomeroy | post-doc | 2001-2004 | Harvard Medical School/Children's Hospital |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Orgel E, Freyer DR, Ullrich NJ, et al. (2020) Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey. Pediatric Blood & Cancer. e28647 |
| Manoharan N, Choi J, Chordas C, et al. (2020) Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma. Journal of Neuro-Oncology |
| de Blank P, Li N, Fisher MJ, et al. (2020) Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genetics in Medicine : Official Journal of the American College of Medical Genetics |
| Klesse LJ, Jordan JT, Radtke HB, et al. (2020) The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities. The Oncologist |
| Miller DT, Cortés-Ciriano I, Pillay N, et al. (2020) Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes. 11 |
| Ullrich NJ, Prabhu SP, Reddy AT, et al. (2020) A Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for Recurrent, Radiographic-Progressive Neurofibromatosis Type 1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis Clinical Trials Consortium Study. Neuro-Oncology |
| Plotkin SR, Duda DG, Muzikansky A, et al. (2019) Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901367 |
| Partap S, Russo S, Esfahani B, et al. (2019) A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer. Pediatric Neurology |
| Miller DT, Freedenberg D, Schorry E, et al. (2019) Health Supervision for Children With Neurofibromatosis Type 1. Pediatrics |
| Zaazoue MA, Manley PE, Kapur K, et al. (2019) Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children. Neurosurgery |